Cargando…
In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P(1)) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P(1) Receptor Modulator
Cenerimod is a potent, selective sphingosine 1-phosphate receptor 1 (S1P(1)) modulator currently investigated in a Phase IIb study in patients with systemic lupus erythematosus (SLE) (NCT03742037). S1P(1) receptor modulators sequester circulating lymphocytes within lymph nodes, thereby reducing path...
Autores principales: | Schlicher, Lisa, Kulig, Paulina, von Münchow, Audrey, Murphy, Mark J., Keller, Marcel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835580/ https://www.ncbi.nlm.nih.gov/pubmed/35163112 http://dx.doi.org/10.3390/ijms23031191 |
Ejemplares similares
-
Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus
por: Strasser, Daniel S, et al.
Publicado: (2020) -
Attenuation of murine sclerodermatous models by the selective S1P(1) receptor modulator cenerimod
por: Kano, Miyu, et al.
Publicado: (2019) -
Cenerimod, a novel selective S1P(1) receptor modulator with unique signaling properties
por: Piali, Luca, et al.
Publicado: (2017) -
Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis
por: Dai, Lan, et al.
Publicado: (2017) -
Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P(1) Receptor Modulator in Healthy Subjects
por: Juif, Pierre-Eric, et al.
Publicado: (2017)